1. Home
  2. ZLAB vs GTX Comparison

ZLAB vs GTX Comparison

Compare ZLAB & GTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • GTX
  • Stock Information
  • Founded
  • ZLAB 2013
  • GTX 2018
  • Country
  • ZLAB China
  • GTX Switzerland
  • Employees
  • ZLAB N/A
  • GTX N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • GTX Auto Parts:O.E.M.
  • Sector
  • ZLAB Health Care
  • GTX Consumer Discretionary
  • Exchange
  • ZLAB Nasdaq
  • GTX Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • GTX 2.0B
  • IPO Year
  • ZLAB 2017
  • GTX N/A
  • Fundamental
  • Price
  • ZLAB $32.54
  • GTX $11.33
  • Analyst Decision
  • ZLAB Buy
  • GTX Strong Buy
  • Analyst Count
  • ZLAB 5
  • GTX 1
  • Target Price
  • ZLAB $54.28
  • GTX $14.00
  • AVG Volume (30 Days)
  • ZLAB 782.4K
  • GTX 3.1M
  • Earning Date
  • ZLAB 08-05-2025
  • GTX 07-24-2025
  • Dividend Yield
  • ZLAB N/A
  • GTX 2.09%
  • EPS Growth
  • ZLAB N/A
  • GTX N/A
  • EPS
  • ZLAB N/A
  • GTX 1.28
  • Revenue
  • ZLAB $418,326,000.00
  • GTX $3,438,000,000.00
  • Revenue This Year
  • ZLAB $44.07
  • GTX $1.06
  • Revenue Next Year
  • ZLAB $49.13
  • GTX $6.41
  • P/E Ratio
  • ZLAB N/A
  • GTX $8.78
  • Revenue Growth
  • ZLAB 43.72
  • GTX N/A
  • 52 Week Low
  • ZLAB $16.01
  • GTX $7.02
  • 52 Week High
  • ZLAB $44.34
  • GTX $12.09
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 40.19
  • GTX 63.54
  • Support Level
  • ZLAB $34.26
  • GTX $10.71
  • Resistance Level
  • ZLAB $35.72
  • GTX $11.57
  • Average True Range (ATR)
  • ZLAB 1.12
  • GTX 0.33
  • MACD
  • ZLAB -0.54
  • GTX 0.12
  • Stochastic Oscillator
  • ZLAB 3.83
  • GTX 88.25

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About GTX Garrett Motion Inc.

Garrett Motion Inc designs, manufactures and sells engineered turbocharger and electric-boosting technologies for light and commercial vehicle original equipment manufacturers (OEMs). The company is a technology leader with expertise in delivering products across gasoline, diesel, natural gas and electrified powertrains. The company also sells its technologies in the aftermarket through its distribution network. The company derives maximum of its revenue from Gas and geographically from Europe.

Share on Social Networks: